Autres langues AstraZeneca PLC

Actions

AZN

GB0009895292

Produits pharmaceutiques

Temps réel estimé Cboe Europe Autres places de cotation 13:41:49 07/08/2026			Varia. 5j.	Varia. 1 janv.
12 017,00 ^GBX	+1,41%		-4,89%	-12,88%

09:37	La Bourse de Stockholm recule en début de séance vendredi	FW
09:07	Horizon de trésorerie assuré jusqu'en 2027 pour Cellectis

Autres langues

07:53	Jefferies belässt Astrazeneca auf 'Buy' - Ziel 17500 Pence
06/08	Blue chips fall but FTSE 250 extends winning run
06/08	Morning Meeting: El oro despierta y los chips sufren una corrección
06/08	Morning Meeting: Die Märkte gleiten langsam in die Sommerflaute
06/08	Markets Drift Gently Towards the Mid-August Lull
06/08	US FDA approves first mRNA flu shot from Moderna
06/08	AstraZeneca, Jaguar Land Rover Gain Access to UK's Fast-Track Visa
05/08	AstraZeneca Is Said to Have Explored Bristol Myers Merger
05/08	FTSE 100 rises, led by Glencore, Next earnings; banks slide
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East Developments
05/08	European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
05/08	INTERVIEW/Novo-Nordisk-CEO offen für ergänzende Übernahmen
05/08	AstraZeneca, Bristol Myers Not Pursuing Merger Talks
05/08	AstraZeneca Pays CSPC $10 Million for Exercise of License Option for Pre-clinical Candidate Program
05/08	AstraZeneca, Bristol Myers Squibb Reportedly Not Discussing Merger
05/08	AstraZeneca, CSPC Pharmaceutical Group Form JV for Biologics Manufacturing Facility in China
05/08	"No hay conversaciones" sobre acuerdo entre AstraZeneca y Bristol Myers: fuente
05/08	'No discussions' over AstraZeneca-Bristol Myers deal, senior source says
05/08	CSPC Pharma Gets $10 Million Milestone Payment from AstraZeneca Under Research Deal
05/08	CSPC Pharma, AstraZeneca Form JV to Build Biologics Manufacturing Facility in China
05/08	Wall Street warms to healthcare stocks as tech trade faces turbulence
04/08	Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies
04/08	Bristol Myers Squibb Potential Deal With AstraZeneca Seen Unlikely as Shareholder Views Diverge, RBC Says
04/08	AstraZeneca Collaborates With Sophia Genetics on Companion Diagnostics for Oncology Therapies